Carregant...

Does the mutant CAG expansion in huntingtin mRNA interfere with exonucleolytic cleavage of its first exon?

BACKGROUND: Silencing mutant huntingtin mRNA by RNA interference (RNAi) is a therapeutic strategy for Huntington’s disease. RNAi induces specific endonucleolytic cleavage of the target HTT mRNA, followed by exonucleolytic processing of the cleaved mRNA fragments. OBJECTIVES: We investigated the clea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Huntingtons Dis
Autors principals: Liu, Wanzhao, Pfister, Edith L., Kennington, Lori A., Chase, Kathryn O., Mueller, Christian, DiFiglia, Marian, Aronin, Neil
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4816656/
https://ncbi.nlm.nih.gov/pubmed/27003665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JHD-150183
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!